Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 11Gastrointestinal 11Head & Neck 7Endocrine 7Dermatologic 5CNS 5Breast 5Sarcoma 4Lymphoid 4Tumor-Agnostic 3Other hematologic neoplasm 2NET 2Genitourinary 2Plasma cell 1Other solid neoplasm 1Myeloid 1Gynecologic 1

Conditions

Leukemia, Myeloid, Acute 20Leukemia, Lymphocytic, Chronic, B-Cell 14Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Hematologic Neoplasms 10Myelodysplastic Syndromes 8Recurrence 7Lymphoma, Non-Hodgkin 4Multiple Myeloma 3Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Hematologic Diseases 3Philadelphia Chromosome 2Neoplasms 2Mastocytosis, Systemic 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Leukemia, Mast-Cell 2Leukemia, Hairy Cell 2Leukemia, Biphenotypic, Acute 2Glioma 2Burkitt Lymphoma 2Bronchiolitis Obliterans Syndrome 2Bone Marrow Diseases 2Waldenstrom Macroglobulinemia 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1

Interventions

trametinib 1pegaspargase 1dabrafenib 1blinatumomab 1asparaginase erwinia chrysanthemi recombinant 1Methotrexate 1Ifosfamide 1Dexamethasone 1Daunorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has announcements × Neoplasms × Other hematologic neoplasm × Clear all
NCT02393859 2024-05-29

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Amgen

Phase 3 Completed
111 enrolled 23 charts 1 FDA
LymphoidOther hematologic neoplasm

Immunoproliferative Disorders, Lymphoproliferative Disorders, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02034110 2023-08-21

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

Novartis

Phase 2 Completed
206 enrolled 40 charts 2 FDA
CNSEndocrineGastrointestinalHead & NeckOther hematologic neoplasmPlasma cellSarcoma

Nonseminomatous germ cell tumor, Biliary Tract Neoplasms, Glioma, Leukemia, Hairy Cell, Multiple Myeloma, Neoplasms, Gastrointestinal Stromal Tumors, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡